Publications

2019 Publications from the Hagopian Lab

Krischer JP, Liu X, Vehik K, Akolkar B, Hagopian WA, Rewers M, She JX, Toppari J, Ziegler AG, Lernmark Å; TEDDY Study Group. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report. Diabetes Care. 2019 Jun; 42(6):1051-1060. PMID: 30967432.

Jacobsen LM, Larsson HE, Tamura RN, Vehik K, Clasen J, et al. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children. Pediatr Diabetes. 2019 May;20(3):263-270. PubMed PMID: 30628751; NIHMSID: NIHMS1008925; PubMed Central PMCID: PMC6456374.

Perdigoto AL, Preston-Hurlburt P, Clark P, Long SA, Linsley PS, et al. Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis. Diabetologia. 2019 Apr;62(4):655-664. PubMed PMID: 30569273; NIHMSID: NIHMS1517070; PubMed Central PMCID: PMC6402971.

2018 and Older Publications from the Hagopian Lab

Salami F, Lee HS, Freyhult E, Elding Larsson H, Lernmark Å, et al. Reduction in White Blood Cell, Neutrophil, and Red Blood Cell Counts Related to Sex, HLA, and Islet Autoantibodies in Swedish TEDDY Children at Increased Risk for Type 1 Diabetes. Diabetes. 2018 Nov;67(11):2329-2336. PubMed PMID: 30104249; PubMed Central PMCID: PMC6198343.

Vatanen T, Franzosa EA, Schwager R, Tripathi S, Arthur TD, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018 Oct;562(7728):589-594. PubMed PMID: 30356183; NIHMSID: NIHMS1506068; PubMed Central PMCID: PMC6296767.

Stewart CJ, Ajami NJ, O’Brien JL, Hutchinson DS, Smith DP, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018 Oct;562(7728):583-588. PubMed PMID: 30356187; NIHMSID: NIHMS1006388; PubMed Central PMCID: PMC6415775.

PNRI is supported by

The SwedishSeattle MetSheratonTryskUSIK L GatesKinzer Partners

Support our innovative genetic research. Become a donor today.